ArticleBMC infectious diseases2026
Four-day versus five-day blood culture incubation: a prospective study of diagnostic performance using the bioMérieux BACT/ALERT VIRTUO system.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBlood stream infections (BSIs) are associated with sepsis, high morbidity and mortality rates, and substantial financial costs. Blood cultures are the gold standard diagnostic test for BSI, with UK Standards for Microbiology Investigations (SMI) recommending routine incubation for 5 days. However, reducing the incubation time to 4 days has been reported to adequately detect true bacteraemia whilst reducing contaminant recovery. In January 2025, Newcastle upon Tyne Hospitals implemented the bioMérieux BACT/ALERT VIRTUO system. This study compared 5-day versus 4-day blood culture incubation, assessing whether a 4-day incubation period is likely to be sufficient for detecting clinically significant bloodstream infections in a UK tertiary centre.
methodsAll blood cultures processed between 22 January 2025 and 31 March 2025, inclusive, were analysed. A case series review assessed the clinical significance of all growth from blood cultures after 4 days' incubation (> 96 h). Two doctors independently appraised the medical records to evaluate the degree to which results influenced clinical management, with double coding undertaken without inter-coder conferral. A resource impact model estimated the local operational cost of extending incubation beyond 4 days.
resultsIn total, 6994 blood culture sets, including 13,103 bottles, were processed from 3221 distinct patients. Only twenty-three (0.18%) bottles flagged positive beyond 4 days' incubation, of which sixteen (69.6%) led to the isolation of contaminants and seven (30.4%) led to the isolation of clinically significant organisms. Retrospective review revealed that growth from only a single bottle yielded information that influenced a change in patient management, translating to one additional clinically meaningful result from over 13,000 extended incubations (0.008%). On the basis of the resource impact model, routine incubation of blood culture for 5 days is estimated to consume an additional 337 h of staff time annually.
conclusionsRoutine incubation of blood cultures beyond 4 days is resource intensive but offers negligible clinical benefits. Our results support review of recommendations outlined in the UK SMI on Sepsis and Systemic or Disseminated infections (S 12). For laboratories equipped with automated continuous monitoring blood culture systems, a routine 4-day incubation period is likely to suffice, with extended incubation reserved for specialist-driven clinical indications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.